Menu

FDA Alerts

Can Pharmacists Improve the Accuracy of Medication Histories?

  • Written by Darrell T. Hulisz, PharmD
  • Category: FDA Alerts
Pharmacist- Versus Physician-Obtained Medication Histories
Reeder TA, Mutnick A
Am J Health Syst Pharm. 2008;65:857-860

Study Summary
About 60% of hospitalized patients have at least 1 error in their medication history that is taken upon admission.[1] The investigators in this study compared medication histories that were obtained by hospital pharmacists with those obtained by physicians. The study was prospective and included 55 patients, age 18 or older, admitted to the internal medicine service at a major teaching hospital. Within several hours of admission, a physician from the internal medicine service obtained a medication history from the patient as part of the overall history and physical examination. Subsequently, within 24 hours of admission, a pharmacist interviewed patients to obtain additional relevant medication history, such as dosages, dosing schedule, use of nonprescription medications and supplements, allergies, pregnancy and lactation status, and vaccination status.

Read more: Can Pharmacists Improve the Accuracy of Medication Histories?

Byetta Linked to Acute Pancreatitis

  • Written by Yael Waknine
  • Category: FDA Alerts
Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byetta, Amylin Pharmaceuticals, Inc), the US Food and Drug Administration (FDA) advised healthcare professionals today.

Read more: Byetta Linked to Acute Pancreatitis

FDA Warns About Injection Site Reactions With Naltrexone

  • Written by Emma P. Hitt, PhD
  • Category: FDA Alerts
Injectable, extended-release naltrexone (Vivitrol, Cephalon), used for the treatment of alcohol dependence, has been linked to adverse injection-site reactions, some requiring surgery, according to a US Food and Drug Administration (FDA) advisory notice to healthcare professionals released yesterday.

Read more: FDA Warns About Injection Site Reactions With Naltrexone

MedWatch - 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation Product

  • Written by Ramaz Mitaishvili
  • Category: FDA Alerts
MedWatch - 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation Product recalled: bacteria contamination

Read more: MedWatch - 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation Product

Levitronix CentriMag Extracorporeal Blood Pumping System

  • Written by Ramaz Mitaishvili
  • Category: FDA Alerts
Levitronix CentriMag Extracorporeal Blood Pumping System: CentriMag Primary Console (with v200 Application Software)
Audience: Cardiothoracic healthcare professionals, perfusionists, hospital risk managers, biomedical engineers

Read more: Levitronix CentriMag Extracorporeal Blood Pumping System

FDA unexpectedly rejects Schering anesthesia drug

  • Written by Ransdell Pierson
  • Category: FDA Alerts
Schering-Plough Corp (nyse: SGP - news - people ) said Friday U.S. regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts and was unanimously recommended by a federal advisory panel.

Read more: FDA unexpectedly rejects Schering anesthesia drug

FDA Extends Consumer Warning on Serrano Peppers from Mexico

  • Written by Ramaz Mitaishvili
  • Category: FDA Alerts
Laboratory testing by the U.S. Food and Drug Administration has confirmed that both a sample of serrano pepper and a sample of irrigation water collected by agency investigators on a farm in the state of Tamaulipas, Mexico (business address is in Nuevo Leon, Mexico) contain Salmonella Saintpaul with the same genetic fingerprint as the strain of bacteria that is causing the current outbreak in the United States.

Read more: FDA Extends Consumer Warning on Serrano Peppers from Mexico

Manufacturer for Wegmans Brand Sorbet Issues an Allergen Alert for Undeclared Milk

  • Written by Ramaz Mitaishvili
  • Category: FDA Alerts

Manufacturer for Wegmans Brand Sorbet Issues an Allergen Alert for Undeclared Milk on a Limited Number of Wegmans Brand Sorbets.

The manufacturer of Wegmans Sorbet is recalling a limited number of 16 oz. Wegmans brand Sorbets because they may contain undeclared milk. People who have an allergy to milk run the risk of a serious or possible life-threatening allergic reaction if they consume the affected products listed below.

Read more: Manufacturer for Wegmans Brand Sorbet Issues an Allergen Alert for Undeclared Milk

EU OKs Drug to Reverse Neuromuscular Blockade

  • Written by Ransdell Pierson
  • Category: FDA Alerts
European regulators have approved a breakthrough new medication to help patients emerge far more quickly from anesthesia than existing treatments, the drug's maker Schering-Plough Corp said on Tuesday.

The drug, called Bridion, was approved by the European Commission, following a recommendation last month by an advisory panel in support of the drug, also known as sugammadex.

Read more: EU OKs Drug to Reverse Neuromuscular Blockade

Amount: 

Color I Color II Color III

Log In or Register